Looking to take more control of their hub data and patient experiences, pharmaceutical leaders are rethinking conventional wisdom regarding hub management. This is paving the way for a new generation of hybrid hubs—where some functions are handled in-house and others are outsourced to hub vendors.
Even so, many leaders are unwilling to manage everything internally, citing existing bandwidth, resource availability and the complexity of required technology. Experts believe this could spark interest in sourcing individual hub functions externally.
Explore the data, as well as the factors and implications of evolving hub management trends, in the new survey.